Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.

OBJECTIVE: To investigate the regulation of expression of the angiogenic cytokine vascular endothelial growth factor (VEGF) in rheumatoid arthritis (RA), in order to determine whether new blood vessel formation could be a potential therapeutic target in RA. METHODS: Dissociated RA synovial membrane...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Paleolog, E, Young, S, Stark, A, McCloskey, R, Feldmann, M, Maini, R
Formato:	Journal article
Idioma:	English
Publicado em:	1998

Registros relacionados

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
por: Taylor, P, et al.
Publicado em: (2000)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
por: Feldmann, M, et al.
Publicado em: (1997)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
por: Paleolog, E, et al.
Publicado em: (1996)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
por: Feldmann, M, et al.
Publicado em: (1997)

Contrasting effects of interferon gamma and interleukin 4 on responses of human vascular endothelial cells to tumour necrosis factor alpha.
por: Paleolog, E, et al.
Publicado em: (1992)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
por: Brennan, F, et al.
Publicado em: (1995)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
por: Maini, R, et al.
Publicado em: (1994)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
por: Maini, R, et al.
Publicado em: (1995)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
por: Buchan, G, et al.
Publicado em: (1988)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
por: Maini, R, et al.
Publicado em: (1998)

Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells.
por: Paleolog, E, et al.
Publicado em: (1994)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
por: Haworth, C, et al.
Publicado em: (1991)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
por: Chu, C, et al.
Publicado em: (1991)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
por: Davis, D, et al.
Publicado em: (1997)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
por: Elliot, M, et al.
Publicado em: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
por: Elliott, M, et al.
Publicado em: (1993)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
por: Taylor, P, et al.
Publicado em: (2001)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
por: Feldmann, M, et al.
Publicado em: (1994)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
por: Maini, R, et al.
Publicado em: (1999)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
por: Williams, R, et al.
Publicado em: (2000)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
por: Ulfgren, A, et al.
Publicado em: (2000)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
por: Feldmann, M
Publicado em: (1996)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
por: Deleuran, B, et al.
Publicado em: (1992)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
por: Elliott, M, et al.
Publicado em: (1994)

Cells with dendritic morphology and bright interleukin-1 alpha staining circulate in the blood of patients with rheumatoid arthritis.
por: Barkley, D, et al.
Publicado em: (1990)

Advanced glycation end products (AGEs) augment production of vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF alpha) in human monocyte-derived macrophages.
por: Pertynska-Marczewska, M, et al.
Publicado em: (2003)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
por: Brennan, F, et al.
Publicado em: (1989)

The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis.
por: Afuwape, A, et al.
Publicado em: (2002)

Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
por: Sebbag, M, et al.
Publicado em: (1997)

Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
por: Ballara, S, et al.
Publicado em: (2001)

Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
por: Katsikis, P, et al.
Publicado em: (1994)

Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis.
por: Field, M, et al.
Publicado em: (1991)

TNF alpha--a pivotal role in rheumatoid arthritis?
por: Brennan, F, et al.
Publicado em: (1992)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
por: Maini, R, et al.
Publicado em: (1994)

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic.
por: Taylor, P, et al.
Publicado em: (1999)

INCREASED EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS ON CELLS ISOLATED FROM RHEUMATOID-ARTHRITIS SYNOVIAL JOINTS
por: Gibbons, D, et al.
Publicado em: (1992)

Correlation of the Complement Decay Accelerating Factor, Tumour Necrosis Factors-alpha, and Interleukin-1 Beta with the Response to Rituximab in Rheumatoid Arthritis Patients
por: Haidar Mohammed Hussein, et al.
Publicado em: (2025-02-01)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
por: Feldmann, M, et al.
Publicado em: (2001)

Mechanism of immune complex-mediated damage: induction of interleukin 1 by immune complexes and synergy with interferon-gamma and tumor necrosis factor-alpha.
por: Chantry, D, et al.
Publicado em: (1989)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
por: Feldmann, M, et al.
Publicado em: (2001)